secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001818093-23-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth reports FY2022 net sales $365.9M (+41% YoY); guides FY2023 $450-470M
--------------------------------------------------------------------------------

- Full year net sales $365.9M (+41% YoY); Q4 net sales $98.1M (+26% YoY).
- Full year net income $44.4M vs net loss $375.1M in 2021; adjusted EBITDA $47.7M (+46% YoY).
- Guides FY2023 net sales $450-470M; affirms 18-20% adjusted EBITDA margin target.
- Confirms long-range 2025 guidance: net sales $600-700M, 25-30% adjusted EBITDA margin.
- Syndeo launch and China expansion key drivers; 8,492 delivery systems sold in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/0001818093-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000181809323000004/skin-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001818093-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer